Join
Live feed
·
PRReleasevia Quantisnow
Keen Vision Acquisition Corporation logo

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction

ByQuantisnow·Wall Street's wire, on your screen.
KVAC· Keen Vision Acquisition Corporation

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KVAC (Keen Vision Acquisition Corporation) and more on Quantisnow.